Form 4: Thermo Fisher Director Boosts Holdings via Deferred Plan

Thermo Fisher Scientific Director R. Alexandra Keith acquired 67.31 phantom stock units through the company's deferred compensation plan, increasing her beneficial ownership.

Summary

• R. Alexandra Keith, a Director of Thermo Fisher Scientific Inc. (TMO), acquired 67.31 phantom stock units.
• The acquisition occurred on September 27, 2025, at a price of $464.24 per unit.
• These units were credited to her account under the Issuer's Deferred Compensation Plan for Directors.
• Following this transaction, R. Alexandra Keith beneficially owns 1,150.49 phantom stock units.
• Phantom stock units are convertible into Common Stock on a 1-for-1 basis.
• Shares are distributable as stock upon cessation of director service or a change of control.

Sentiment

Score: 6

Explanation: Slightly positive due to a director increasing their beneficial ownership, indicating continued alignment with shareholder interests, though it's a routine compensation event rather than an open market purchase.

Positives

• Director R. Alexandra Keith increased her beneficial ownership in Thermo Fisher Scientific Inc. through the acquisition of 67.31 phantom stock units.
• The transaction aligns the director's interests with those of shareholders, as the units are convertible to common stock.

Negatives

• No negative information is disclosed in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The phantom stock units are distributable as common stock upon cessation of director service (for any reason) or a change of control.

Management Comments

• Phantom Stock Units are convertible into Common Stock on a 1-for-1 basis.
• Stock units were credited to the Reporting Person's account as of September 27, 2025, at a price of $464.24 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors.
• Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end.
• The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Industry Context

This filing reports a routine insider transaction related to director compensation and does not provide information directly related to broader industry trends or competitors.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• The acquisition of phantom stock units by Director R. Alexandra Keith under the Issuer's Deferred Compensation Plan for Directors constitutes a related party transaction, as it involves compensation from the company to a board member.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with long-term shareholder value through equity ownership.
• Directors: Provides a mechanism for deferred compensation and equity accumulation.

Next Steps

• Phantom stock units will be distributed as common stock upon the cessation of director service or a change of control.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary acquisition of phantom stock units by a director as part of a deferred compensation plan. It does not reflect a discretionary investment decision or provide new information about the company's operational or financial performance that would warrant a change in investment recommendation.

Keywords

Thermo Fisher Scientific, TMO, Insider Transaction, Form 4, Director, Phantom Stock Units, Deferred Compensation, Equity Acquisition, R. Alexandra Keith